Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersDermatology Physician in Palo Alto, CA
NPI: 1003043340Primary Practice Location
Palo Alto Center
795 El Camino Real, Palo Alto, CA
Primary Employer
Palo Alto Medial Foundation
sutterhealth.org
HQ Phone
Get M.D. Shira's Phone Numberphone_androidMobile
Get M.D. Shira's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2008 - 2026
American Board of Dermatology
Dermatology
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 2007
UCSF School of Medicine
medschool.ucsf.edu
Residency • Dermatology
2008 - 2011
Santa Clara Valley Medical Center
Internship • Internal Medicine
2007 - 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 385 | 537 |
| 2 | 17110Destruction of up to 14 skin growths | 292 | 377 |
| 3 | 17000Destruction of skin growth | 252 | 337 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 242 | 276 |
| 5 | 17003Destruction of 2-14 skin growths | 208 | 1,116 |
Conflicts of Interest in Academic Research: Policies, Processes, and Attitudes
Authors: Shira Lipton, Elizabeth A. Boyd, Lisa Bero
Lead Sponsor: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, OTHER: Best Practice, RADIATION: Intensity-Modulated Radiation Therapy, PROCEDURE: Computed Tomography, DRUG: Placebo Administration, RADIATION: Image Guided Radiation Therapy, DRUG: MnSOD Mimetic BMX-001
Lead Sponsor: Boehringer Ingelheim
Intervention / Treatment: DRUG: Brigimadlin
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: DIAGNOSTIC_TEST: DetermaRX
